A phase II study of local therapy only (stereotactic radiosurgery and or surgery) for treatment of up to 5 brain metastases from HER2+ breast cancer
For patients who have HER2 positive breast cancer which has spread to the brain (metastasised) the main treatment options for these brain metastases are as follows: Whole Brain Radiotherapy (WBRT), or Stereotactic Radiosurgery (SRS), or Neurosurgery (NS) This study aims to show that brain metastases are able to be controlled by SRS and/or NS without the need for WBRT.
Primary Sponsor
Trans-Tasman Radiation Oncology Group (TROG)
Accrual Target
25
Closing Date of Accrual
22nd December 2020
Trial Chairperson
Dr Claire Phillips, Peter MacCallum Cancer Centre, VIC
Trial Contact
LocalHero@trog.com.au
Clinical Trial Registration
Related Post
October 18, 2022
NINJA Radiation Therapy Trial participant tells his journey to treatment
The journey to becoming the 200th participant for the
September 6, 2022
The gift that kept on giving
The NewyWay Coffee Collaboration Newcastle marketing agency, The Marketing
